Literature DB >> 21366732

suPAR - a future risk marker in bacteremia.

Jesper Eugen-Olsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21366732     DOI： 10.1111/j.1365-2796.2011.02372.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  22 in total

1.  Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.

Authors:  Jimmi Nielsen; Rasmus Røge; Sofie Gry Pristed; Anne Grethe Viuff; Henrik Ullum; Lise Wegner Thørner; Thomas Werge; Torkel Vang
Journal:  Schizophr Bull       Date:  2014-08-25       Impact factor: 9.306

Review 2.  Developments for improved diagnosis of bacterial bloodstream infections.

Authors:  A J M Loonen; P F G Wolffs; C A Bruggeman; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-22       Impact factor: 3.267

3.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

4.  Association of the Circulating Supar Levels with Inflammation, Fibrinolysis, and Outcome in Severe Burn Patients.

Authors:  Jian-Chang Lin; Xiao-Dong Chen; Zhao-Rong Xu; Lin-Wen Zheng; Zhao-Hong Chen
Journal:  Shock       Date:  2021-12-01       Impact factor: 3.454

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Inflammatory markers in the second trimester prior to clinical onset of preeclampsia, intrauterine growth restriction, and spontaneous preterm birth.

Authors:  Sofie Haedersdal; Jannie D Salvig; Martine Aabye; Christian W Thorball; Morten Ruhwald; Steen Ladelund; Jesper Eugen-Olsen; Niels J Secher
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

7.  Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.

Authors:  Thomas Huneck Haupt; Janne Petersen; Gertrude Ellekilde; Henrik Hedegaard Klausen; Christian Wandall Thorball; Jesper Eugen-Olsen; Ove Andersen
Journal:  Crit Care       Date:  2012-07-23       Impact factor: 9.097

8.  Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.

Authors:  Alexander Koch; Frank Tacke
Journal:  Crit Care       Date:  2011-12-15       Impact factor: 9.097

Review 9.  suPAR as a prognostic biomarker in sepsis.

Authors:  Katia Donadello; Sabino Scolletta; Cecilia Covajes; Jean-Louis Vincent
Journal:  BMC Med       Date:  2012-01-05       Impact factor: 8.775

10.  The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.

Authors:  Anna Gustafsson; Lennart Ljunggren; Mikael Bodelsson; Ingrid Berkestedt
Journal:  Biomark Insights       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.